TACE and other ADAM proteases as targets for drug discovery
- 5 April 2001
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 6 (8), 417-426
- https://doi.org/10.1016/s1359-6446(01)01738-x
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Metalloprotease‒disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cellsBiochemical Journal, 2000
- Trafficking of Human ADAM 12-L: Retention in the trans-Golgi NetworkBiochemical and Biophysical Research Communications, 2000
- Evidence for an interaction of the metalloprotease‒disintegrin tumour necrosis factor α convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease‒disintegrin MDC9 with a novel MAD2-related protein, MAD2βBiochemical Journal, 1999
- Isolation of Two Novel Metalloproteinase-Disintegrin (ADAM) cDNAs That Show Testis-Specific Gene ExpressionBiochemical and Biophysical Research Communications, 1999
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- The Metallo-Disintegrin ADAM10 (MADM) from Bovine Kidney Has Type IV Collagenase Activityin VitroBiochemical and Biophysical Research Communications, 1998
- KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α productionLife Sciences, 1997
- Expression of Members of the Novel Membrane Linked Metalloproteinase Family ADAM in Cells Derived from a Range of Haematological MalignanciesBiochemical and Biophysical Research Communications, 1997
- Purification of ADAM 10 from bovine spleen as a TNFα convertaseFEBS Letters, 1997
- Refined 2·0 Å X-ray Crystal Structure of the Snake Venom Zinc-endopeptidase Adamalysin II: Primary and Tertiary Structure Determination, Refinement, Molecular Structure and Comparison with Astacin, Collagenase and ThermolysinJournal of Molecular Biology, 1994